MET Financials

Income Statement
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
19.1B
-19.9%
23.8B
+37.2%
17.4B
+0.1%
17.3B
-6.6%
18.6B
Cost of Revenue
11.9B
-29.3%
16.8B
+61.8%
10.4B
-3.7%
10.8B
-8.8%
11.8B
Gross Profit
7.2B
+2.4%
7.0B
+0.7%
7.0B
+6.4%
6.6B
-2.8%
6.8B
Operating Expenses
17.6B
-21.9%
22.5B
+38.0%
16.3B
-0.3%
16.4B
-5.1%
17.2B
R&D
SG&A
0
-100.0%
13.9B
0
0
0
Operating Income
1.5B
+14.7%
1.3B
+23.9%
1.1B
+7.2%
980.0M
-25.9%
1.3B
EBITDA
1.5B
+437.2%
-443000000
-142.2%
1.1B
+7.2%
980.0M
-25.9%
1.3B
Net Income
1.2B
+42.4%
816.0M
-9.5%
902.0M
+22.7%
735.0M
-22.6%
950.0M
EPS (Basic)
$1.75
+48.3%
$1.18
-4.1%
$1.23
+18.3%
$1.04
-19.4%
$1.29
EPS (Diluted)
$1.74
+47.5%
$1.18
-3.3%
$1.22
+18.4%
$1.03
-19.5%
$1.28
Shares (Diluted)
655.7M
-1.0%
662.1M
-1.0%
669.1M
-0.9%
675.0M
-1.7%
687.0M
MetLife (MET) — Financials